Aug 29 |
The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
|
Aug 29 |
Amgen's GLP-1 Upside Is Not Priced In
|
Aug 28 |
Eli Lilly Launches Discounted Versions of Obesity Drug Zepbound
|
Aug 28 |
Amgen: Growth Is Still A Better Choice
|
Aug 27 |
With 79% institutional ownership, Amgen Inc. (NASDAQ:AMGN) is a favorite amongst the big guns
|
Aug 26 |
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
|
Aug 25 |
3 Unstoppable Dividend Stocks to Buy Right Now
|
Aug 21 |
Pathalys secures $105m to advance SHPT drug through approval
|
Aug 21 |
Lilly (LLY) Up 3% on Obesity Drug Cutting Diabetes Risk
|
Aug 21 |
Amgen’s Otezla launched for paediatric plaque psoriasis in US
|